These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23337772)

  • 1. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala.
    Parker JA; McCullough KA; Field BC; Minnion JS; Martin NM; Ghatei MA; Bloom SR
    Int J Obes (Lond); 2013 Oct; 37(10):1391-8. PubMed ID: 23337772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Nesfatin-1-Containing Neurones in the Hypothalamus and Brainstem by Peripheral Administration of Anorectic Hormones and Suppression of Feeding via Central Nesfatin-1 in Rats.
    Saito R; So M; Motojima Y; Matsuura T; Yoshimura M; Hashimoto H; Yamamoto Y; Kusuhara K; Ueta Y
    J Neuroendocrinol; 2016 Sep; 28(9):. PubMed ID: 27203571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice.
    Kjaergaard M; Salinas CBG; Rehfeld JF; Secher A; Raun K; Wulff BS
    Neuropeptides; 2019 Feb; 73():89-95. PubMed ID: 30471778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
    Thiele TE; Seeley RJ; D'Alessio D; Eng J; Bernstein IL; Woods SC; van Dijk G
    Brain Res; 1998 Aug; 801(1-2):164-70. PubMed ID: 9729361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2.
    Jelsing J; Galzin AM; Guillot E; Pruniaux MP; Larsen PJ; Vrang N
    Brain Res Bull; 2009 Mar; 78(4-5):202-10. PubMed ID: 19038314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
    Züger D; Forster K; Lutz TA; Riediger T
    Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol modulates the anorexic response to central glucagon-like peptide 1.
    Maske CB; Jackson CM; Terrill SJ; Eckel LA; Williams DL
    Horm Behav; 2017 Jul; 93():109-117. PubMed ID: 28558993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake.
    Cegla J; Troke RC; Jones B; Tharakan G; Kenkre J; McCullough KA; Lim CT; Parvizi N; Hussein M; Chambers ES; Minnion J; Cuenco J; Ghatei MA; Meeran K; Tan TM; Bloom SR
    Diabetes; 2014 Nov; 63(11):3711-20. PubMed ID: 24939425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.
    Dossat AM; Lilly N; Kay K; Williams DL
    J Neurosci; 2011 Oct; 31(41):14453-7. PubMed ID: 21994361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
    Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
    Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for glucagon-like peptide-1 in the central regulation of feeding.
    Turton MD; O'Shea D; Gunn I; Beak SA; Edwards CM; Meeran K; Choi SJ; Taylor GM; Heath MM; Lambert PD; Wilding JP; Smith DM; Ghatei MA; Herbert J; Bloom SR
    Nature; 1996 Jan; 379(6560):69-72. PubMed ID: 8538742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.
    Baumgartner I; Pacheco-López G; Rüttimann EB; Arnold M; Asarian L; Langhans W; Geary N; Hillebrand JJ
    J Neuroendocrinol; 2010 Jun; 22(6):557-63. PubMed ID: 20298455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the central anorexigenic mechanism of glucagon-like peptide 1 in Japanese quail (Coturnix japonica).
    Failor M; Bohler M; Cao C; Gilbert E; Cline M
    Gen Comp Endocrinol; 2023 Aug; 339():114292. PubMed ID: 37088166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the central pathways involved in the emetic and behavioural responses to exendin-4 in the ferret.
    Lu Z; Yeung CK; Lin G; Yew DT; Andrews PL; Rudd JA
    Auton Neurosci; 2017 Jan; 202():122-135. PubMed ID: 27692857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.